ENDOTHELIN-1 AND ENDOTHELIN-3 BINDING TO RAT NEPHRONS

被引:56
|
作者
TAKEMOTO, F
UCHIDA, S
OGATA, E
KUROKAWA, K
机构
[1] UNIV TOKYO,FAC MED,DEPT INTERNAL MED 1,TOKYO 113,JAPAN
[2] UNIV TOKYO,FAC MED,DEPT INTERNAL MED 4,TOKYO 113,JAPAN
来源
AMERICAN JOURNAL OF PHYSIOLOGY | 1993年 / 264卷 / 05期
关键词
GLOMERULUS; COLLECTING DUCT; SCATCHARD ANALYSIS; BQ-123; BQ-3020;
D O I
10.1152/ajprenal.1993.264.5.F827
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The existence of endothelin (ET) receptor subtypes has recently been implicated in the different biological effects of ET in various tissues. Indeed, the cDNAs for two types of ET receptors, ET(A) and ET(B), have been cloned. To further gain insights into ET function in the kidney we examined I-125-labeled ET-1 and ET-3 binding to microdissected rat nephron segments. Specific ET-1 binding was highest in the inner medullary collecting duct, whereas the cortical and outer medullary collecting ducts as well as glomeruli showed moderate binding. There was low, although not significant, ET-1 binding to the early portion of the proximal tubule. Other nephron segments displayed little ET-1 binding. The binding profile of ET-3 along the nephron markedly resembled that of ET-1. Scatchard analyses of binding of ET-1 and ET-3 using cortical collecting ducts revealed a single class of receptor for both ET-1 and ET-3; apparent dissociation constants were 2.05 +/- 0.72 and 2.58 +/- 0.32 nM, and maximal binding capacity values were 0.408 +/- 0.058 and 0.511 +/- 0.047 fmol/mm, respectively. Displacement of I-125-ET-1 binding by unlabeled ET-3 was similar to that produced by unlabeled ET-1. Furthermore, a specific ET(B) agonist, BQ 3020, almost completely inhibited I-125-ET-1 binding in cortical collecting ducts, whereas a specific ETA antagonist, BQ 123, had little effect. These data indicate that cortical collecting ducts express ET(B) receptors, to which both ET-1 and ET-3 bind equally.
引用
收藏
页码:F827 / F832
页数:6
相关论文
共 50 条
  • [1] THE FATE OF RADIOIODINATED ENDOTHELIN-1 AND ENDOTHELIN-3 IN THE RAT
    ANGGARD, E
    GALTON, S
    RAE, G
    THOMAS, R
    MCLOUGHLIN, L
    DENUCCI, G
    VANE, JR
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 13 : S46 - S49
  • [2] ENDOTHELIN-1 AND ENDOTHELIN-3 BINDING TO ET(B) RECEPTORS IN RAT RENAL TUBULES
    UCHIDA, S
    TAKEMOTO, F
    OGATA, E
    KUROKAWA, K
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 22 : S177 - S180
  • [3] COMPARISON OF THE EFFECTS OF ENDOTHELIN-1 AND ENDOTHELIN-3 ON THE RAT STOMACH
    WALLACE, JL
    KEENAN, CM
    MACNAUGHTON, WK
    MCKNIGHT, GW
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 167 (01) : 41 - 47
  • [4] Effect of endothelin-1 and endothelin-3 on rat luteal function
    Usuki, S
    Kotani, E
    Nakauchi, T
    Otani, S
    Kubo, T
    ADVANCES IN COMPARATIVE ENDOCRINOLOGY, TOMES 1 AND 2, 1997, : 1587 - 1590
  • [5] EXPRESSION OF ENDOTHELIN-1 AND ENDOTHELIN-3 IN THE RAT-KIDNEY
    FIRTH, JD
    SCHRICKER, K
    RATCLIFFE, PJ
    KURTZ, A
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL FLUID AND ELECTROLYTE PHYSIOLOGY, 1995, 269 (04): : F522 - F528
  • [6] DIFFERENTIATION OF ENDOTHELIN-1 AND ENDOTHELIN-3 CONCENTRATIONS
    GERBES, AL
    GASTROENTEROLOGY, 1993, 105 (05) : 1591 - 1591
  • [7] Localization of endothelin-1 and endothelin-3 in the cochlea
    Franz, P
    HauserKronberger, C
    Egerbacher, M
    Bock, P
    Stach, M
    Quint, C
    Aharinejad, S
    ACTA OTO-LARYNGOLOGICA, 1997, 117 (03) : 358 - 362
  • [8] DIFFERENT AFFINITIES AND SELECTIVITIES OF ENDOTHELIN-1 AND ENDOTHELIN-3 BINDING TO VARIOUS RAT-TISSUES
    JENG, AY
    SAVAGE, P
    SORIANO, A
    BALWIERCZAK, JL
    BIOCHEMISTRY INTERNATIONAL, 1990, 22 (04): : 669 - 676
  • [9] Endothelin-1 and Endothelin-3 Regulate Endothelin Receptor Expression in Rat Coronary Arteries
    Skovsted, Gry Freja
    Kilic, Semsi
    Edvinsson, Lars
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 117 (05) : 297 - 305
  • [10] ENDOTHELIN-1 AND ENDOTHELIN-3 STIMULATE OVARIAN STEROIDOGENESIS
    USUKI, S
    SAITOH, T
    SUZUKI, N
    KITADA, C
    GOTO, K
    MASAKI, T
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 : S256 - S259